Immune Reconstitution in the Patients with Talasemia Major after Hematopoietic Stem Cell Transplantation

Erman B., Adakli Aksoy B.

TURKISH JOURNAL OF IMMUNOLOGY, cilt.8, sa.3, ss.113-119, 2020 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 8 Sayı: 3
  • Basım Tarihi: 2020
  • Doi Numarası: 10.25002/tji.2020.1238
  • Dergi Adı: TURKISH JOURNAL OF IMMUNOLOGY
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.113-119
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Introduction: Beta-thalaccemia (beta-TM) is one of the most common, autosomal recessive inherited hematologic disorder in the world. Since hematopoietic stem cell transplantation (HSCT) is the only curative treatment, determination of cellular immune reconstitution is crucial for understanding of a successful clinical outcome. Here, we evaluated lymphoid reconstitution in pediatric patients with thalassemia major after stem cell transplantation.